Dmitry Kaminskiy

General Partner at Deep Knowledge Ventures
1
ICOs
$ 5,163,000
Projects Raised
United Kingdom
Country
About Dmitry Kaminskiy
Dmitry Kaminskiy is an innovative entrepreneur and investor who is active in the fields of BioTech, FinTech, BlockChain, Artificial Intelligence. Kaminskiy is a co-founder and a managing partner at Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects. Considering the significant growth of interest to the Longevity industry, Deep Knowledge Life Sciences, a London-based subsidiary investment fund, has increased its activity in 2017 and will actively expand its portfolio to catch the wave edge of the rising trend “Investing in Longevity”. Insilico Medicine is the flagship among portfolio companies, a leading pioneer at the intersection of Artificial Intelligence, precision medicine and Longevity. Dmitry is a frequent speaker on the topics of AI and Longevity. During the last year he spoke at conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, and at the Future Finance Forum in Seoul “AI in Finance”, as well as several others at Oxford and Cambridge Universities. Dmitry Kaminskiy and Deep Knowledge Ventures are actively involved in the rising Crypto Economy working on several Blockchain projects in the field of LegalTech and RegTech with the aim to create sophisticated platforms and frameworks to apply novel financial tools and strategies to optimise distribution of venture funding to provide DeepTech projects with sufficient investment budgets. But the most priority project for Dmitry in his life is building Global Longevity Consortium as the decentralized knowledge platform and next generation Non-Profit foundation which will serve as the collective mind of the Longevity sphere and will be the key driver for the Longevity Index Hedge Fund, a project on the intersection and convergence of Cryptoeconomy, Novel Financial Strategies, Precision Medicine and Longevity.
Associated ICOs